Skip to content
Abierto
Menu

Solicitation

Fenofibrate Nanocrystalize

SPE2D220R0073

Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Golden State Medical Supply, Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov.

Modification P00004 SPE2D2-21-D-0131 No Cost-Settlement Termination for Convenience. Modification P00003 SPE2D2-21-D-0131 to incorporate FAR Claluse 52.204-27 Prohibition on a Bytedance Covered Application (JUN 2023) into contract. Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024. Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.

Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT. Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Golden State Medical Supply, Inc.
UEI
GQLDJJ8AQNN5
CAGE
1HT23
Vendor location
Camarillo, CA
Contract
SPE2D221D0131
Obligated
$0.00, potential $1
Actions
1 between January 9, 2024 and January 9, 2024
Competition
Full and Open Competition, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
4610072330!manufacture/Distributor BR-PH
Match
solicitation number SPE2D220R0073 equals the FPDS solicitation identifier; same awarding office SPE2D2 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 9, 2024

    Solicitation

    Due October 23, 2020 at 3:00 PM EDT. SAM.gov, notice 983dc145b41f46b3810acc6497292449

Points of contact

Also open from this buyer